PUMA BIOTECHNOLOGY, INC. PBYI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-03-21
PUMA BIOTECHNOLOGY, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| WILSON TROY EDWARD | director | 2026-06-12 | Sell | 10,800 | $7.20 |
| MOYES JAY M | director | 2026-06-12 | Sell | 22,000 | $7.22 |
| Senderowicz Adrian | director | 2026-06-12 | Sell | 27,000 | $7.20 |
| Dorval Allison | director | 2026-06-12 | Sell | 11,610 | $7.20 |
| Stuglik Brian M | director | 2026-06-12 | Sell | 8,100 | $7.20 |
| Dorval Allison | director | 2026-06-11 | Grant | 27,000 | — |
| Cesano Alessandra | director | 2026-06-11 | Grant | 27,000 | — |
| WILSON TROY EDWARD | director | 2026-06-11 | Grant | 27,000 | — |
Source: SEC EDGAR filings · CIK 0001401667 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.